These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1284 related articles for article (PubMed ID: 26212035)

  • 1. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]   [Full Text] [Related]  

  • 3. Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer.
    Ma Z; Feng J; Guo Y; Kong R; Ma Y; Sun L; Yang X; Zhou B; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Cheng Y; Zha D; Liu S
    Oncol Res; 2017 Jul; 25(6):887-895. PubMed ID: 28244855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
    Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
    Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT3 is correlated with the malignancy of non-small cell lung cancer.
    Xiong Y; Wang M; Zhao J; Wang L; Li X; Zhang Z; Jia L; Han Y
    Int J Oncol; 2017 Mar; 50(3):903-910. PubMed ID: 28197634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway.
    Du C; Li DQ; Li N; Chen L; Li SS; Yang Y; Hou MX; Xie MJ; Zheng ZD
    Sci Rep; 2017 Feb; 7():42876. PubMed ID: 28216662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
    Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
    Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
    Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
    Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
    J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and glucocorticoid kinase 1 promoted the growth and migration of non-small cell lung cancer cells.
    Xiaobo Y; Qiang L; Xiong Q; Zheng R; Jianhua Z; Zhifeng L; Yijiang S; Zheng J
    Gene; 2016 Jan; 576(1 Pt 2):339-46. PubMed ID: 26548813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.
    Yue W; Zhao X; Zhang L; Xu S; Liu Z; Ma L; Jia W; Qian Z; Zhang C; Wang Y; Yang X
    Clin Lung Cancer; 2011 Jan; 12(1):43-50. PubMed ID: 21273179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
    Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
    Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.
    Xu X; Sun PL; Li JZ; Jheon S; Lee CT; Chung JH
    J Thorac Oncol; 2011 Apr; 6(4):716-24. PubMed ID: 21336184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway.
    Xue Y; Jia X; Li L; Dong X; Ling J; Yuan J; Li Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2885-2891. PubMed ID: 30119889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.